Skip to content
Open Data Finder
Open Government Canada

Guidance Document - Comparative Bioavailability Standards: Formulations Used for Systemic Effects

Published by Health Canada | Santé Canada

About this dataset

To ensure that sponsors of new drug submissions have the information necessary to comply with Sections C.08.002(2)(h), C.08.002.1(2)(c)(ii) and C.08.003(3) of the Food and Drug Regulations with respect to comparative bioavailability and comparative pharmacodynamic studies used in support of the safety and efficacy of a drug.

Guidance Document - Comparative Bioavailability Standards: Formulations Used for System… · Open Data Finder